Copyright
©The Author(s) 2025.
World J Cardiol. Apr 26, 2025; 17(4): 104717
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.104717
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.104717
Table 1 An overview of different substances of abuse and their effects on the cardiovascular system, including their associations with heart failure
Substance | Mechanism of action | Cardiovascular effects | Association with HF | Ref. |
Cocaine | Blocks dopamine, norepinephrine, and serotonin reuptake | Vasoconstriction, tachycardia, arrhythmias, and hypotension | Associated with cardiomyopathy, MI, arrhythmias, and increased HF risk | [30,46] |
Amphetamines | Stimulates release of norepinephrine and dopamine | Tachycardia, hypertension, cardiomyopathy | Linked to hypertensive heart disease and increased HF risk | [47,48] |
Alcohol | CNS depressant altering cardiac function | Chronic use leads to alcoholic cardiomyopathy, hypertension, arrhythmias | High association with dilated cardiomyopathy leading to HF | [30,49] |
Opioids | Binds to opioid receptors, decreases pain, induces euphoria | Bradycardia, hypotension, respiratory depression | Chronic use may lead to myocardial injury and increase HF risk | [48,50] |
Nicotine | Increases heart rate and blood pressure | Endothelial dysfunction, tachyarrhythmias, hypertension | Increases HF risk through oxidative stress and inflammation | [49,51] |
Marijuana | Activates cannabinoid receptors | Tachycardia, hypotension, changes in vascular tone | Limited evidence; potential role in MI and arrhythmias | [50,52] |
Methamphetamine | Elevates dopamine release | Cardiovascular strain, hypertension | High risk of cardiomyopathy and HF due to structural remodeling | [47,52] |
Synthetic cannabinoids | Potent synthetic THC, stronger than natural cannabinoids | Tachyarrhythmias, MI, blood pressure changes | Severe cardiovascular complications including HF | [50,52] |
Ecstasy (MDMA) | Increases serotonin, norepinephrine, and dopamine levels | Hypertension, tachycardia, hyperthermia | Acute HF risks during dehydration and hyperthermia episodes | [51,52] |
Benzodiazepines | CNS inhibition causing sedation | Hypotension, respiratory depression | Limited association with HF; can exacerbate existing conditions | [48,51] |
- Citation: Parizad R, Batta A, Hatwal J, Taban-sadeghi M, Mohan B. Emerging risk factors for heart failure in younger populations: A growing public health concern. World J Cardiol 2025; 17(4): 104717
- URL: https://www.wjgnet.com/1949-8462/full/v17/i4/104717.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i4.104717